Hydroxy Compound Active Ingredients TRIZ Cases

D-cycloserine acts as a competitive NMDAR antagonist to mitigate anxiety and akathisia caused by antipsychotic medications.

Direct compression of pure cannabidiol into tablets by controlling particle size and moisture content, eliminating flow agents that compromise purity.

A supplement formulation combines cannabinoids, carotenoids, and hyaluronic acid to enhance transdermal absorption.

STRO-1+ stem cells migrate to infarcted brain regions via paracrine signaling, reducing lesion volume and improving functional recovery.

Adhesive bandage pod applies topical workout muscle recovery composition to specific muscles, avoiding whole-body distribution from oral supplements.

Segmenting the formulation prevents Maillard reactions and hyperkalemia risk while allowing stable vitamin incorporation in a simplified device.

Clofoctol targets glioma stem cells to reduce tumor formation, addressing neuroglioma recurrence and drug resistance.

Combining statins with cannabinoids enhances bioavailability to lower effective doses while mitigating muscle problems and adverse effects.

Pre-treating NK and T cells with Nrf2 activators counters tumor microenvironment suppression, improving adoptive cell therapy efficacy.

Methanol prodrugs provide sustained formate release to support immune cell survival, avoiding rapid elimination and toxicity from direct administration.

Topical cannabidiol treats antidepressant-induced sexual dysfunction by delivering localized therapeutic effects without systemic drug interactions.

Correlates moon phases with zodiac signs to schedule planting, watering, and harvesting for healthier plants and superior CBD products.

Vitamin A administration inhibits scar tissue formation, resolving the trade-off between healing and functional recovery in spinal cord injuries.

Combining chlorhexidine digluconate, benzocaine, and hydrocortisone reduces outbreak duration and severity without prescription side effects.

Multi-component formulation combines DMSO, curcumin, and energy sources to restore cerebral blood flow.

Administering a non-racemic mixture of R-beta-hydroxybutyrate and S-beta-hydroxybutyrate facilitates easier transition into ketosis while reducing hypoglycemia.

Novel cannabinoid formulations combine purified cannabinoids with the discarded remainder fraction containing waxes and lipids.

Specific antagonists inhibit the OR5K1 receptor response to Furaneol, eliminating malodorous molecules without causing fragrance discomfort or re-emission.

Volatile organic compounds activate ectopic olfactory receptors to induce GLP-1 and PYY secretion, avoiding adverse events from injectable analogs.

Emulsion condensation process controls polymeric particle topology through second emulsifier concentration adjustments.

New crystalline polymorphs of 1,6-dibromo-1,6-dideoxy-dulcitol improve manufacturing safety and solubility to treat metastatic cancers.

Combining MALAT1 silencing with all-trans retinoic acid to induce apoptosis in leukemia cells.

Cross-linked acrylic homopolymer forms stable oil-in-water emulsions without surfactants, preserving active agent integrity.

Bacterial ghost composition reduces PD-L1-positive cells and increases cytotoxic T cells to overcome high procedure complexity in cancer treatment.

Combines phosphodiesterase 3A modulators with interferons to overcome drug resistance in low PDE3A expressing cancers by upregulating SLFN12.

Anti-HCN4 antibodies isolate sinoatrial node-like cells from pluripotent stem cell cultures for precise electrophysiological characterization.

Polyvinyl acetate and vinyl laurate-vinyl acetate copolymers in medical chewing gum mask bitter cannabinoid taste while maintaining release profiles.

Oral genistein and DHA emulsion boosts collagen synthesis, bypassing topical limits.

Ionic crosslinking creates a stable nanocomposite gel that extends drug residence time and reduces systemic toxicity in targeted delivery.

Pin1 biomarkers detect monomeric protein levels to stratify patients, resolving the contradiction between therapeutic efficacy and implementation complexity.

Merges alpha-2 agonist and inositol into one dosage form to address impulsivity and emotional lability.

Emu oil mediates retinoid delivery to reduce skin irritation while enhancing transdermal penetration of active ingredients.

Targeting Staphylococcus delta toxin blocks mast cell-mediated cytokine release, resolving inadequate treatment for atopic dermatitis.

N-acetyl glucosamine administration reduces viral RNA replication and lowers viral loads through prophylactic dosing.

Surfactant-based isotretinoin dispersion eliminates food effect variability while maintaining high drug absorption.

Replacing unstable coenzyme Q with stable tyrosol and hydroxytyrosol lowers inhibitor cost while maintaining effective apoBNOX inhibition.

A hydrophobic polymer matrix coats textile substrates to disperse active compounds in a crystalline form.

A cannabinoid herbal composition combines ashwagandha, Bacopa monnieri, and CBD to enhance mental acuity.

Derivatized C60-serinol acts as a universal antioxidant that scavenges free radicals, reducing oxidative stress and DNA damage across multiple organ systems.

A powder nasal irrigation solution combining lactated Ringers with xylitol for daily cleansing and post-surgery care.

Self-assembled lecithin structures in triglycerides protect vitamin A from oxidation and isomerization during storage without requiring expensive solvents.

Phospholipid nanoparticles encapsulate cannabinoids to bypass first-pass metabolism, increasing bioavailability 2- to 8-fold while reducing required doses.

Ultrasound energy creates microchannels in the stratum corneum to drive medicants through skin layers.

A topical composition uses penetration enhancers and humectants to move cannabinoids into the dermis.

High dimer vitamin E derivatives solubilize non-polar compounds via micelle formation, preventing precipitation and maintaining beverage clarity.

A topical formulation combines cannabidiol with TRPM8 agonists to enable transdermal delivery of active agents.

Extruded chewing gum generates saliva to deliver at least 10% of cannabinoids to the oral mucosa within five minutes, preventing excessive swallowing.